This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 May 18;152(10):JC5-6, JC5-7, JC5-8.

doi: 10.7326/0003-4819-152-10-201005180-02007.

ACP Journal Club. Oral fingolimod was more effective than placebo for relapsing-remitting multiple sclerosis

Affiliations

PMID: 20479024
DOI: 10.7326/0003-4819-152-10-201005180-02007

Comment

ACP Journal Club. Oral fingolimod was more effective than placebo for relapsing-remitting multiple sclerosis

James Hughes. Ann Intern Med. 2010.

. 2010 May 18;152(10):JC5-6, JC5-7, JC5-8.

doi: 10.7326/0003-4819-152-10-201005180-02007.

Author

Affiliation

¹ Tamworth Rural Referral Hospital, Tamworth, New South Wales, Australia.

PMID: 20479024
DOI: 10.7326/0003-4819-152-10-201005180-02007

No abstract available

PubMed Disclaimer

Comment on

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P; FREEDOMS Study Group. Kappos L, et al. N Engl J Med. 2010 Feb 4;362(5):387-401. doi: 10.1056/NEJMoa0909494. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089952 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Atypon